• A re|evaluation of the influential STAR*D study of antidepressants ...🔍
• For Best Depression Treatment Get Star|D Results To Your Doctor🔍
• Vilazodone for the treatment of major depressive disorder🔍
• Acerca del influyente estudio STAR*D sobre la clínica con ...🔍
• Effectiveness of common antidepressants🔍
• Facilitating Thought Progression to Reduce Depressive Symptoms🔍
• Efficacy and acceptability of second|generation antipsychotics with ...🔍
• A Double|Blind Randomized Placebo|Controlled Trial of Citalopram ...🔍

A re-evaluation of the influential STAR*D study of antidepressants ...

A re-evaluation of the influential STAR*D study of antidepressants has exposed it as a fraud, now recognized by the psychiatric community.

For Best Depression Treatment Get Star-D Results To Your Doctor

If you want the best depression treatment, you need to get the STAR*D depression study results to your doctor right now. Watch this to find ...

Vilazodone for the treatment of major depressive disorder

Evidence review: In clinical trials, including two Phase III studies and two Phase IV studies, vilazodone has been shown to have efficacy ...

Acerca del influyente estudio STAR*D sobre la clínica con ...

Abstract: Randomized controlled trials (RCTs) show that antidepressants (ADs) in major depressive disorder (MDD) are only slightly superior to placebo. However, ...

Effectiveness of common antidepressants: a post market release study

Using the robust, and large predictors of remission, and propensity to prescribe an antidepressant, the study created 16,770 subgroups of ...

Facilitating Thought Progression to Reduce Depressive Symptoms

Methods: A randomized clinical trial was conducted, comparing changes in depression symptoms between participants who used the app in the ...

Efficacy and acceptability of second-generation antipsychotics with ...

STAR*D trial suggests that patients who do not respond adequately to initial antidepressant agents may benefit from subsequent treatment ...

A Double-Blind Randomized Placebo-Controlled Trial of Citalopram ...

109) (Table 2). Groups did not differ in severity of depressive symptoms as measured with the CDRS at the week 8 of the trial (b = 0.02, 95% ...

Efficacy and Safety of Transcranial Magnetic Stimulation in the Acute ...

The most comprehensive demonstration of this in the recent literature is from the large, open-label, seminaturalistic STAR*D trial (Trivedi et al. 2006). In ...

STARD 2015 - Search for reporting guidelines - EQUATOR Network

... D, Rennie D, de Vet HC. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for ...

Study protocol for “MDMA-assisted therapy as a treatment for major ...

Discussion: This proof of principle trial will inform the development of fully powered clinical trials, optimize the protocol for the administration of MDMA-AT ...

Similar Items: Star-D: Lessons learned and future implications

Pharmacogenetics studies in STAR*D: Strengths, limitations, and results · STAR*D: Revising conventional wisdom · STAR*D: Revising conventional wisdom.

Antidepressant efficacy of low-frequency repetitive transcranial ...

Difference in treatment outcome in outpatients with anxious versus nonanxious depres sion: a STAR*D report. ... D trial. EClinicalMedicine ...

Acerca del influyente estudio STAR*D sobre la clínica con ...

The Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Study was conducted to validate this practice. This study is the largest and the most ...

Medication augmentation after the failure of SSRIs for depression.

Primary outcome: Remission of symptoms as defined by score of 7 or less on 17-item Hamilton Rating Scale for Depression at end of study. Secondary outcomes: ...

Randomized trial of a depression management program in high ...

Depression severity was measured using the Hamilton Depression Rating Scale (Ham-D) and functional status using the Medical Outcomes Study 20-item short form ( ...

Untitled

Auditory entrainment coordinates cortical-BNST-NAc triple time ...

After grouping, a K-nearest neighbor algorithm determined the decision boundary between the groups (Figure 1D). The study design was as follows.

CAUSALab News

Yu-Han Chiu, the lead author of the study, is a CAUSALab researcher collaborator and current faculty member at Penn State College of Medicine. This work was ...

StarMS Trial | CTRU | The University of Sheffield

Autologous Stem Cell Transplantation versus Alemtuzumab, Ocrelizumab, Ofatumumab or Cladribine in Relapsing-Remitting Multiple Sclerosis (MS). THIS TRIAL IS ...